Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mallinckrodt, C
67  Ergebnisse:
englisch X
Personensuche X
?
1

Efficacy and safety of continuous every-2-week dosing of ix..:

Langley, R.G. ; Papp, K. ; Gooderham, M....
British Journal of Dermatology.  178 (2018)  6 - p. 1315-1323 , 2018
Link: https://doi.org/10.1111/..
 
?
2

Recent Developments in the Prevention and Treatment of Miss..:

Mallinckrodt, C. ; Roger, J. ; Chuang-Stein, C....
Therapeutic Innovation & Regulatory Science.  48 (2014)  1 - p. 68-80 , 2014
Link: https://doi.org/10.1177/..
 
?
3

P.2.c.027 The relevance of treating painful somatic symptom..:

Wise, T.N. ; Meyers, A.L. ; Desaiah, D....
European Neuropsychopharmacology.  17 (2007)  - p. S356 , 2007
Link: https://doi.org/10.1016/..
 
?
4

(741):

Fishbain, D. ; Hall, J. ; Meyers, A....
The Journal of Pain.  8 (2007)  4 - p. S36 , 2007
Link: https://doi.org/10.1016/..
 
?
5

Duloxetine in the treatment of major depressive disorder: C..:

STEWART, D ; WOHLREICH, M ; MALLINCKRODT, C..
Journal of Affective Disorders.  94 (2006)  1-3 - p. 183-189 , 2006
Link: https://doi.org/10.1016/..
 
?
6

Duloxetine for the treatment of major depressive disorder: ..:

MALLINCKRODT, C ; PRAKASH, A ; ANDORN, A..
Journal of Psychiatric Research.  40 (2006)  4 - p. 337-348 , 2006
Link: https://doi.org/10.1016/..
 
?
7

Incidence and duration of antidepressant-induced nausea: du..:

GREIST, J ; MCNAMARA, R ; MALLINCKRODT, C..
Clinical Therapeutics.  26 (2004)  9 - p. 1446-1455 , 2004
Link: https://doi.org/10.1016/..
 
?
8

P.1.035 Onset of improvement in emotional and painful physi..:

Wohlreich, M. ; Brannan, S. ; Mallinckrodt, C....
European Neuropsychopharmacology.  13 (2003)  - p. S189 , 2003
Link: https://doi.org/10.1016/..
 
?
9

Central and peripheral temperature changes in sheep followi..:

MacLeay, J.M. ; Lehmer, E. ; Enns, R.M....
Maturitas.  46 (2003)  3 - p. 231-238 , 2003
Link: https://doi.org/10.1016/..
 
?
10

Safety and tolerability of the antidepressant duloxetine:

Tran, P. ; Mallinckrodt, C. ; Detke, M...
European Neuropsychopharmacology.  12 (2002)  - p. 215-216 , 2002
Link: https://doi.org/10.1016/..
 
?
11

Duloxetine in the treatment of depression: A double-blind p..:

Mallinckrodt, C. ; Goldstein, D.J. ; Lu, Y....
European Neuropsychopharmacology.  12 (2002)  - p. 214 , 2002
Link: https://doi.org/10.1016/..
 
?
12

Mechanical strain, induced noninvasively in the high-freque..:

Rubin, C. ; Turner, A.S. ; Mallinckrodt, C....
Bone.  30 (2002)  3 - p. 445-452 , 2002
Link: https://doi.org/10.1016/..
 
?
13

Random blood glucose levels in patients with schizophrenia ..:

Allison, D.B. ; Cavazzoni, P. ; Beasley Jr., C.M....
European Neuropsychopharmacology.  11 (2001)  - p. S280 , 2001
Link: https://doi.org/10.1016/..
 
?
14

Efficacy and safety of duloxetine in the treatment of major..:

Goldstein, D.J. ; Mallinckrodt, C. ; Lu, Y..
European Neuropsychopharmacology.  11 (2001)  - p. S212 , 2001
Link: https://doi.org/10.1016/..
 
?
15

The effect of raloxifene on coronary arteries in aged ovari..:

Gaynor, J. S. ; Monnet, E. ; Selzman, C....
Journal of Veterinary Pharmacology and Therapeutics.  23 (2000)  3 - p. 175-179 , 2000
Link: https://doi.org/10.1046/..
 
1-15